KEQUConsumer Cyclical · Furnishings, Fixtures & Appliances

KEQU Stock Forecast: Kewaunee Scientific Corp. Price Predictions for 2026-2027

Last close, 11 Sept 2026

$34

−0.26% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 52 of 100 as at 12 Sept 2026 — in the upper half.

Market cap

$98.8M

Ticker Nerd rank

52 / 100

Median analyst target

—

Analysts covering

Revenue$71.4M−7.5% y/y

Operating income$5.2M

Net income$3.7M

Free cash flow$4.5M

Quarterly, 7 quarters to 30 Apr 2026 · latest quarter's figure shown

Total return, dividends reinvested

−6.4%

−4.8%

YTD

−7.9%

−20.0%

From 52W high

−25.3%

From 52W low

+1.4%

$34

$46

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

KEQU stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Kewaunee Scientific Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026

52 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance

Accruals

Size

Quality

Value

Volatility

Growth

Revisions

Momentum

Issuance (91): The share count has been shrinking and the company is not leaning on new borrowing.

Momentum (13): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

KEQU stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on KEQU, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts

1 Buy0 Hold0 Sell

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. KEQU appears on the weeks it earns a place.

Performance

KEQU vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Kewaunee Scientific Corp. returned −20.0% against +17.5% for the S&P 500, dividends included.

KEQU vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

KEQU analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Kewaunee Scientific Corp. (KEQU) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 12.5×
Price / sales: 0.4×
Price / book: 1.3×
EV / EBITDA: 7.0×

Growth & margins

Revenue growth (YoY): −6.7%
Earnings growth (YoY): −44.8%
Gross margin: 29.8%
Operating margin: 4.8%
Net margin: 3.0%

Returns & dividend

Return on equity: 12.5%
Return on assets: 5.1%
Dividend yield: 2.2%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Kewaunee Scientific Corp. (KEQU) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Kewaunee Scientific Corp. has a market value of $98.8M and an enterprise value of $148.7M.
Revenue in the twelve months to 30 Apr 2026: $282.0M. The latest quarter shrank 6.7% year on year.
Net income over the same four quarters: $10.5M, a 3.7% net margin.
Diluted earnings per share, trailing twelve months: $3.22.
Free cash flow in the twelve months to 30 Apr 2026: $14.7M, after $3.9M of capital spending.
Shares outstanding: 2.9M.
Trailing P/E: 12.5×; forward P/E: 15.9× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.22%, paying out 0% of earnings.
Kewaunee Scientific Corp. employs 1,231 people — $229K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 Apr 2026 · market figures as at 13 Sept 2026

Data provided by Twelve Data

Peers

KEQU vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelFurnishings, Fixtures & Appliances

Company	Market cap	TKN rank
KEQUKewaunee Scientific Corp.	$98.8M	52
VIRCVirco Manufacturing Corp.	$97.7M	47
COOKTraeger, Inc.	$135.1M	37
HOFTHooker Furnishings Corp.	$137.8M	94
BSETBassett Furniture Industries, Inc.	$153.2M	89
LCUTLifetime Brands, Inc.	$194.4M	89
LOVEThe Lovesac Co.	$205.6M	87

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Kewaunee Scientific Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest KEQU news & analysis

Kewaunee Q1 Earnings Fall Y/Y Despite International Strength

Zacks Investment Research · 10 Sept 2026negative

Kewaunee Scientific reported fiscal Q1 earnings that fell year over year, reflecting weaker sales and LPG volumes. These declines were partly offset by stronger international profitability and cost control, according to Zacks Investment Research.

Why it matters — A KEQU watcher would care because the year-over-year earnings decline points to softer domestic sales in the quarter, even though international profitability and cost measures provided some offset.

Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027

PRNewsWire · 9 Sept 2026neutral

Kewaunee Scientific Corporation announced its results for the first quarter of fiscal year 2027, which ended July 31, 2026. The company released these results in a Sept. 9, 2026 announcement from Statesville, N.C.

Why it matters — KEQU watchers would care because the announcement provides the company's latest quarterly financial results, which are a key indicator of its recent performance.

Kewaunee Scientific Posts Record $282M Revenue, Maps Fiscal 2027 Growth Investments

MarketBeat · 29 Aug 2026positive

Kewaunee Scientific reported record revenue of $282 million and, during its fiscal 2026 annual meeting of stockholders, outlined continued investments in product development, manufacturing capacity, international expansion, and potential acquisitions. The company also mapped out growth investments for fiscal 2027.

Why it matters — KEQU watchers would care because the company is reporting record revenue while signaling where it intends to invest for future growth, indicating an active expansion strategy.

Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027

PRNewsWire · 25 Aug 2026neutral

Kewaunee Scientific Corporation announced it will release its first quarter fiscal year 2027 financial results on Wednesday, September 9, 2026, after the close of trading. The announcement was made on August 25, 2026.

Why it matters — This sets the date for investors and market watchers to receive the company's latest quarterly financial performance data.

FAQ

Frequently asked questions about KEQU stock

Is KEQU stock a buy right now?

Of the 1 analysts covering Kewaunee Scientific Corp., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Kewaunee Scientific Corp. 52 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank KEQU?

As at 12 Sept 2026, Kewaunee Scientific Corp. ranks 52 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (91 of 100).

What is the KEQU stock forecast for 2030?

No analyst covering Kewaunee Scientific Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for KEQU are extrapolating price history, which says nothing about the business.

How has KEQU stock performed over the past year?

Kewaunee Scientific Corp. returned -20.0% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Kewaunee Scientific Corp. do?

What is the latest news on KEQU?

The most recent item we track (Zacks Investment Research, 10 Sept 2026): "Kewaunee Q1 Earnings Fall Y/Y Despite International Strength". Kewaunee Scientific reported fiscal Q1 earnings that fell year over year, reflecting weaker sales and LPG volumes. These declines were partly offset by stronger international profitability and cost control, according to Zacks Investment Research.

Company

About Kewaunee Scientific Corp.

Kewaunee Scientific Corporation Common Stock represents Kewaunee Scientific Corporation, a specialized manufacturer and installer of laboratory, healthcare, and technical furniture and related infrastructure products. Kewaunee Scientific Corporation serves customers that require durable, purpose-built environments for scientific research, clinical settings, education, and other technical applications. Its product portfolio includes laboratory casework, fume hoods, containment solutions, and custom furnishings designed to support safe, organized, and efficient workspaces. The company operates across domestic and international markets through its current business segments, providing integrated solutions that combine design, manufacturing, and installation services. With a focus on highly regulated and performance-driven environments, Kewaunee Scientific Corporation plays a niche role in the broader healthcare equipment and scientific infrastructure market.

CEO Mr. Thomas David Hull III · 1,231 employees · United States · https://kewaunee.com